Get 15% off your first 3 months + Free Shipping. Use code: TRANSFORM15

GLP-1 Weight Loss by State: Obesity Rates & Medicaid Coverage

Transformation Health Medical Team June 16, 2026 6 min read

Adult obesity affects 33.1% of US adults as of 2024 (CDC Nutrition, Physical Activity, and Obesity - BRFSS), but the rate, and the help available to treat it, varies widely by state. The tables below show adult obesity prevalence for every state and DC, alongside whether each state’s Medicaid program covers GLP-1 medications for weight loss. Select your state for the full picture and your telehealth options.

A note on Medicaid: only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026, and coverage almost always requires prior authorization. Where a state does not cover these medications for weight loss, a cash-pay telehealth program is one option a licensed provider may discuss.

Adult obesity and GLP-1 Medicaid coverage by state

StateAdult obesityRankMedicaid (weight loss)
West Virginia41.4%1Generally not covered
Mississippi40.4%2Covered (with PA)
Louisiana39.2%3Generally not covered
Arkansas38.9%4Generally not covered
Alabama38.9%5Generally not covered
Indiana38.4%6Generally not covered
Nebraska37.6%7Generally not covered
Kansas37.6%8Covered (with PA)
Tennessee37.6%9Generally not covered
Wisconsin37.4%10Covered (with PA)
Kentucky37.2%11Generally not covered
South Dakota37.0%12Generally not covered
Ohio36.9%13Generally not covered
Oklahoma36.8%14Generally not covered
North Dakota36.8%15Generally not covered
Iowa36.6%16Generally not covered
Delaware36.6%17Covered (with PA)
Michigan36.1%18Restricted
Texas35.6%19Generally not covered
Georgia35.4%20Generally not covered
South Carolina34.6%21Recently ended
Missouri34.6%22Generally not covered
North Carolina34.5%23Covered (with PA)
New Mexico34.5%24Generally not covered
Pennsylvania34.2%25Recently ended
Nevada34.2%26Generally not covered
Illinois34.2%27Generally not covered
Alaska34.0%28Generally not covered
Oregon33.5%29Generally not covered
Arizona33.3%30Generally not covered
Maine33.2%31Generally not covered
Maryland32.7%32Generally not covered
Idaho32.7%33Generally not covered
Wyoming32.5%34Generally not covered
Virginia32.3%35Generally not covered
Minnesota32.3%36Covered (with PA)
Connecticut32.0%37Generally not covered
Washington31.5%38Generally not covered
Rhode Island31.1%39Generally not covered
New Hampshire31.1%40Recently ended
Utah31.0%41Generally not covered
Montana31.0%42Generally not covered
Florida29.6%43Generally not covered
New York29.5%44Generally not covered
California29.1%45Recently ended
Vermont29.0%46Covered (with PA)
New Jersey27.7%47Generally not covered
Massachusetts27.0%48Covered (with PA)
Hawaii27.0%49Generally not covered
District of Columbia25.5%50Generally not covered
Colorado25.0%51Generally not covered

Rank 1 = highest obesity prevalence. Full sources and methodology are listed below.

See If You Qualify in Under 5 Minutes

Our online assessment is reviewed by a U.S.-licensed physician. No insurance needed. Cancel anytime.

Get Started
HIPAA Compliant Visa Mastercard Apple Pay Google Pay FSA/HSA

Data sources and methodology

  • Adult obesity: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System. Prevalence is the percentage of adults with a body mass index of 30 or higher, based on self-reported height and weight, so figures may differ from measured surveys such as NHANES. National rate: 33.1% (2024).
  • Medicaid coverage: KFF, Medicaid Coverage of and Spending on GLP-1s, as of January 2026. Only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026, and coverage changes frequently. Status shown here is for general information; confirm current benefits with your state Medicaid program.
  • Data current as of: 2024 CDC release. Page last updated: June 16, 2026.

Important: Compounded medications are not FDA-approved products. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. Medicaid coverage information is general and changes frequently; confirm with your state program. All prescriptions require evaluation by an independent, licensed healthcare provider. Not all patients will qualify. Results vary by individual.

Get Evaluated for a GLP-1 Program

Complete a free online assessment. An independent, licensed provider reviews your information and determines whether a GLP-1 program is appropriate for you. All-inclusive pricing covers medication, lab work, and provider care. No hidden fees. Cancel anytime.

Use code TRANSFORM15 for 15% off your first 3 months + Free Shipping

Get Started
Provider-Led Care
Locked-In Pricing
Safety & Quality

Medical Disclaimer: All medical services are provided by independent, U.S.-licensed healthcare providers. Compounded medications are not FDA-approved. Results vary by individual and are not guaranteed. Our providers only prescribe when clinically appropriate. For residents of AR, DC, DE, MS, NM, RI, and WV, state regulations require an initial live video consultation before a prescription can be written.

Our Commitment to Your Care: Medical & Legal Disclosures

Our Platform & Your Independent Medical Team

Transformation Health is a modern technology platform designed to connect you with high-quality, convenient telehealth services. We facilitate your access to medical care; we do not provide the medical care ourselves.

All medical services are provided by independent, U.S.-licensed healthcare providers. These dedicated professionals are responsible for all clinical decisions, including diagnosis, treatment, and prescribing. Your confidential doctor-patient relationship is established directly with your independent provider to ensure your care is compliant, personalized, and focused on your unique health goals.

Understanding Your Medication: Compounded Formulations

The medications available through this platform are prepared by U.S.-based, state-licensed compounding pharmacies. These facilities are highly regulated and must adhere to standards set by their respective State Boards of Pharmacy.

Compounding allows pharmacists to create personalized medication formulations to meet specific patient needs, such as providing an alternative for a medication that is in shortage or creating a formulation without an ingredient a patient is allergic to.

It is important to understand that, as is the case with all compounded medications, these specific formulations are not FDA-approved. The FDA-approval process is designed for mass-produced, branded drugs. Compounded medications (which may utilize salt forms like semaglutide sodium/acetate) are prepared for individual patients and do not undergo the same large-scale FDA review for safety and efficacy. Your licensed provider will determine if this type of medication is the appropriate treatment for you. Transformation Health is not affiliated with, nor endorsed by, the manufacturers of any brand-name medications mentioned (e.g., Ozempic®, Wegovy®, Mounjaro®).

A Note on Health Information

We are passionate about providing helpful, informative content on our website. Please note that this information is intended for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Your health journey is unique, so we encourage you to always consult your personal physician or another qualified health provider with any questions about a medical condition or before starting any new treatment program.

Regarding Patient Results & Testimonials

We are proud of our patients' success and love sharing their stories. The testimonials, reviews, and health outcomes shared on this site may represent the real-life experiences of individual users.

It's important to understand that results are not guaranteed and will vary from person to person. Your personal success depends on a wide range of factors, including your starting point, your adherence to the program, lifestyle habits, and your unique medical history.

To help visualize the patient journey and protect the privacy of our community, some content - including images, text, and personal stories - may be created using third-party Artificial Intelligence (AI) solutions. These AI-generated assets are fictional and are used for illustrative purposes only. They do not represent actual patients or specific clinical outcomes.

Brand & Trademark Information

You may see references to brand-name medications like Wegovy®, Ozempic®, Mounjaro®, and Zepbound®. These are registered trademarks of their respective owners (Novo Nordisk A/S and Eli Lilly and Company) and are FDA-approved medications. The compounded medications available through this platform are not affiliated with or endorsed by the owners of these trademarks. They are alternative formulations prescribed by your provider to meet your specific clinical needs.